Press Releases for WYE

Press Releases
Pfizer Reports Third-Quarter 2009 Results
IQPC's Corporate Energy Management Summit to Feature Experts From, EMC, the EPA, and the DOE
Stock on the Move: SUWN - October 15, 2009
UPI NewsTrack Business
Abbott to buy Solvay division for $6.6B
FDA requires promethazine warning
Fitch: Credit Quality Stable for Global Pharma Sector With Increase of New Drug Approvals in 2Q'09
Cylex, Inc. Appoints Brad L. Stewart As Chief Executive Officer and Chairman of the Board
McGill prof named in ghostwriting scandal
Metastorm Debuts New Customer Testimonial Videos ; Seven Successful Organizations Share Insights on Using EA, BPA, BPM Software in Season 5 of the 'Metastorm Customers Speak Out' Series
Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024
StockPreacher.com Issues Trading Outlook for Nabi Biopharmaceuticals
Wyeth Provides Regulatory Update on Prevnar 13* in the United States
Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook
Paladin Reports 2009 Second Quarter Financial Results
Ligand Terminates Long-Term Lease Obligation
Wyeth ghostwriters pushed hormone therapy
Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval
Ligand Pharmaceuticals Announces Second Quarter Results
MicroStrategy Announces Second Quarter 2009 Financial Results
Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
Pfizer Reports Second-Quarter 2009 Results; Increases Full-Year 2009 Adjusted Diluted EPS(1) Guidance
Ellsworth Fund Ltd. Announces Earnings and Financial Update
Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
Johnson Controls Announces Web-Based Greenhouse Gas Reporting System ; System Measures, Manages and Reports Organizations' Global Carbon Footprints
Wyeth Announces Results of the Company's Offer Relating to Holder Right to Surrender Convertible Debentures
Wyeth Consumer Healthcare Announces the Availability of New Centrum Ultra Line of Multivitamins Specially Formulated For Women and Men
Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
Wyeth's Prevenar 13* Receives First Approval
Study Evaluating Efficacy and Safety of Two Low-dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Published
Livingston Securities "Healthcare Investment Series" Webinar Covers Emerging Models for Pharma Exits and Deals
UPI NewsTrack Health and Science News
New 'river blindness' drug shows promise
MattsonJack Adds Indications to Epi Database
Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
JDA Software Group Selects Tenrox On-Demand Service to Aid Global Professional Services Automation Management
Wyeth Announces Holder Right to Surrender Convertible Debentures
Ted Kennedy given big advance for memoirs
Wyeth Declares Common Stock Dividend
Reportlinker Adds R&D Cost Cutting: Managing Cost Containment and Safeguarding Productivity
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
Reliant Energy Selects Grey As Its Branding and Advertising Agency
Progenics Announces Initiation of RELISTOR Clinical Trials in Japan by Ono Pharmaceutical
Pfizer Announces Completion Of European Debt Offering
Bancroft Fund Ltd. Announces Earnings and Financial Update
Healthcare Industry Is Not Unaffected By Economy
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
Inovio Biomedical and VGX Pharmaceuticals Stockholders Overwhelmingly Approve Proposed Merger
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
BDI Pharma, Inc. Surpasses XYNTHA Distribution Projections
Wyeth accused of defrauding government
Final Wyeth painting published in journal
Feds, 16 states join suits against Wyeth
Inovio Biomedical Reports First Quarter 2009 Financial Results
Federal Circuit Affirms Denial of Preliminary Injunction Regarding Teva's Generic Protonix® Tablets
Inhibitex Reports First Quarter 2009 Financial Results
Progenics Announces First Quarter Financial Results
Future of Natural Gas Burns Brightly for El Paso Corporation, an Industrial Info News Alert
MattsonJack to Present at Access to Innovative Cancer Therapies in 2009 - 4th Annual Oncology Economics Forum
Ellsworth Fund Ltd. Announces Earnings and Financial Update
Pharmaceutical-Bio Industry to Inject $5.6 Billion for Capital and Maintenance Project Starts in 2Q09, an Industrial Info News Alert
Sotheby's Announces 2009 First Quarter Results
Perrigo Reports Record Third Quarter
Phase 3 Clinical Study of RELISTOR Presented at American Pain Society Meeting Showed Positive Activity for the Treatment of Opioid-Induced Constipation in Chronic, Non-Cancer Pain Patients
FDA Grants Priority Review Status to Prevnar 13 Marketing Application
Pharma and Biotech Company Wyeth Holds Steady in First Fiscal Quarter, an Industrial Info News Alert
Evercore Partners Reports First Quarter 2009 Results; Declares Quarterly Dividend Of $0.12 Per Share
Vivalis : Significant Growth in Revenues and Cash Flows in Q1 2009
Wyeth Reports Earnings Results for the 2009 First Quarter
Pfizer Reports First-Quarter 2009 Results; Reaffirms Full-Year 2009 Financial Guidance for Revenues and Adjusted Results(1)
Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Wyeth Announces Full Redemption of $2 Convertible Preferred Stock - Apr 23 2009 4:59PM
Wyeth Announces Full Redemption of $2 Convertible Preferred Stock - Apr 23 2009 2:51PM
Pfizer / Wyeth Merger Will Force Big Pharma to Consolidate Says New Report By URCH Publishing
MattsonJack Hires Gary Sullivan, Augments Business Development Expertise
Morgan Stanley Reports First Quarter Results
Sepracor Announces Patent Interference Proceedings (and Schedule) Against Wyeth for Claims Related to O-Desmethylvenlafaxine Succinate (Marketed As PRISTIQ®)
Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition
Zacks Analyst Blog Highlights: Pfizer Inc., Wyeth, Satyam Computer Services Ltd., Abbott Laboratories and Boston Scientific Inc.
Ng Tee Khiang Appointed to Inovio Biomedical's Board of Directors
MattsonJack to Lead Workshop at Pharmaceutical Strategic Outlook and BIO-Windhover
Research and Markets: Global Strategic Report Analyzes the Anti-Aging Products in Millions of US$ and Profiles 799 of the Most Prolific Companies in the Industry
Elan and Wyeth Plan to Amend Bapineuzumab Phase 3 Protocols
Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
Fairholme's Berkowitz and Pfizer's Kindler - Conference Call This Monday
Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Small Companies Must Use Business Development Best Practices to Garner Licensing Agreements With Pharma, Says Cutting Edge Information
Zacks Analyst Blog Highlights: Pfizer Inc., Wyeth Pharmaceuticals, Schering-Plough, China Mobile, and AIG
Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings
Impax Pharmaceuticals to Co-Promote Wyeth's Pristiq®
Impax Pharmaceuticals to Co-Promote Wyeth's Pristiq(R)
Dyax Amends Loan Agreement With Cowen Healthcare Royalty Partners for an Additional $15 Million
Research and Markets: In October 2008, the Indonesian Industry Minister Was Reportedly Considering Removing Pharmaceuticals From the Nationalistic 'Negative Investment List'